Lupus myocarditis. Case report;Miocardite lúpica. A propósito de um caso clínico

Revista Portuguesa de Cardiologia

Volumn 24, Issue 10, 2005, Pages 1247-1257

  Costa, Susana ^a   Franco, Fátima ^a   Monteiro, Pedro ^a   Oliveira, Luís ^a   Vieira, Henrique ^a   Garrido, Luís ^a   Gonçalves, Lino ^a   Gomes, Henrique ^a   Campos, Mário ^a   Providência, Luís A ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Myocarditis; Systemic lupus erythematosus

Indexed keywords

AMINOPHYLLINE; AMIODARONE; CALCIUM; CARVEDILOL; DIGOXIN; ENALAPRIL; IRBESARTAN; LEVOSIMENDAN; MAGNESIUM SULFATE; METHYLPREDNISOLONE; OMEPRAZOLE; PREDNISOLONE; RADIOISOTOPE; VITAMIN B COMPLEX;

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; FEMALE; HEART FAILURE; HEMODIALYSIS; HUMAN; HYPERTENSION; LABORATORY TEST; MYOCARDITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYOCARDITIS;

EID: 28844461022     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Moder KG, Miller TD, Tazelaar HD. Cardiac Involvement in Systemic Lupus Erythematosus. Mayo Clin Proc 1999; 74:275-84.
2. De Inocencio J, Lovell DJ. Cardiac Function in Systemic Lupus Erythematosus. J Rheumatol 1994;21:2147-56.
3. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-98.
4. Dec GW Jr., Palacios IF, Fallon JT, Aretz HT, Mills J, Lee D C-S, Johnson RA. Active myocarditis in the spectrum of acute dilated cardiomyopathies - Clinical features, histologic correlates and clinical outcome. N Engl J Med 1985;312:885-90.
5. Anandasabapathy S, Frishman WH. Innovative Drug Treatment for Viral and Autoimmune Myocarditis. J Clin Pharmacol 1998;38:295-308.
6. Davies MJ, Ward DE. How can myocarditis be diagnosed and should it be treated? Br Heart J 1992;68:346-7.
7. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of Cardiac Troponin I associated with Myocarditis: Experimental and Clinical Correlates. Circulation 1997;95:163-8.
8. Lauer B, Niederau C, Kühl U, Schannwell M, Pauschinger M, Strauer B-E, Schultheiss H-P. Cardiac Troponin T in Patients With Clinically Suspected Myocarditis. J Am Coll Cardiol 1997;30:1354-9.
9. Doherty NE III, Feldman G, Maurer G, Siegel RJ. Echocardiographic findings in Systemic Lupus Erythematosus. Am J Cardiol 1988;61:1144.
10. Dec GW, Palacios I, Yasuda T, Fallon JT, Khaw BA, Strauss HW, Haber E. Antimyosin Antibody Cardiac Imaging: Its Role in the Diagnosis of Myocarditis. J Am Coll Cardiol 1990;16:97-104.
11. Martin J, Sarai K, Schindler M, van de Loo A, Yoshitake M, Beyersdorf F. MEDOS HIA-VAD Biventricular Assist Device for Bridge to Recovery in Fulminant Myocarditis. Ann Thorac Surg 1997;63:1145-6.
12. Marelli D, Laks H, Amsel B, Jett GK, Couper G, Ardehali A, Galindo A, Drinkwater DC. Temporary Mechanical Support with the BVS 5000 Assist Device during Treatment of Acute Myocarditis. J Card Surg 1997;12:55-9.
13. Kawahito K, Murata S-I, Yasu T, Adachi H, Ino T, Saito M, Misawa Y, Fuse K, Shimada K. Usefulness of Extracorporeal Membrane Oxygenation for Treatment of Fulminant Myocarditis and Circulatory Collapse. Am J Cardiol 1998;82: 910-1.
14. Follath F, Cleland JGF, Just H, Papp JGY, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell E-P, Lehtonen L. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002;360:196-202.
15. Cleland JGF, Takala A, Apajasalo M, Zethraeus N, Kobelt G. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial. Eur J Heart Fail 2003:101-8.
16. Lehmann A, Boldt J, Kirchner J. The role of Ca++-sensitizers for the treatment of heart failure. Curr Opin Crit Care 2003 Oct; 9(5):337-44.
17. McBride BF, White CM. Levosimendan: implications for clinicians. J Clin Pharmacol 2003 Oct; 43(10):1071-81.
18. Innes CA, Wagstaff AJ. Levosimendan: a review of its use in the management of acute decompensated heart failure. Drugs 2003;63(23):2651-71.
19. Sorsa T, Pollesello P, Permi P, Drakenberg T, Kilpelainen I. Interaction of levosimendan with cardiac troponin C in the presence of cardiac troponin I peptides. J Mol Cell Cardiol 2003 Sep; 35(9):1055-61.
20. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22: 1527-60.